{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T03:58:54Z","timestamp":1768795134050,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nefro.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T01:27:37Z","timestamp":1556069257000},"page":"497-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study"],"prefix":"10.1016","volume":"39","author":[{"given":"Pere","family":"Domingo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Suarez-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernando","family":"Knobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Antela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Ram\u00f3n","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Fulladosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2019.01.009_bib0130","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nefro.2019.01.009_bib0135","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015","volume":"3","author":"Wang","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.nefro.2019.01.009_bib0140","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/cid\/cir628","article-title":"Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses","volume":"53","author":"Capeau","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nefro.2019.01.009_bib0145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1473-3099(15)00063-8","article-title":"Prediction of geriatric HIV in 2030","volume":"15","author":"Vance","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nefro.2019.01.009_bib0150","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw097","article-title":"HIV as a chronic disease: evaluation and management of non-AIDS-defining conditions","volume":"3","author":"Serrano-Villar","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.nefro.2019.01.009_bib0155","first-page":"75","article-title":"Morbidity in older HIV-infected patients: impact of long-term antiretroviral use","volume":"16","author":"Guaraldi","year":"2014","journal-title":"AIDS Rev"},{"key":"10.1016\/j.nefro.2019.01.009_bib0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12603-015-0608-7","article-title":"Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era \u2013 role of chronic renal disease","volume":"20","author":"Hentzien","year":"2016","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.nefro.2019.01.009_bib0165","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/infdis\/jit043","article-title":"Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study","volume":"207","author":"Ryom","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nefro.2019.01.009_bib0170","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2352-3018(15)00211-8","volume":"3","author":"Mocroft","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.nefro.2019.01.009_bib0175","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.nefro.2019.01.009_bib0180","unstructured":"VACH (Grupo Espa\u00f1ol de Estudios VIH\/AICH). Available at: http:\/\/vach.es\/."},{"issue":"suppl.","key":"10.1016\/j.nefro.2019.01.009_bib0185","first-page":"1","article-title":"K\/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.01.009_bib0190","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2019.01.009_bib0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2019.01.009_bib0200","doi-asserted-by":"crossref","first-page":"e1001809","DOI":"10.1371\/journal.pmed.1001809","article-title":"Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study","volume":"12","author":"Mocroft","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.nefro.2019.01.009_bib0205","first-page":"78","article-title":"Prevalence of chronic renal disease in Spain: results of the EPIRCE study","volume":"30","author":"Otero","year":"2010","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2019.01.009_bib0210","first-page":"223","article-title":"Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study","volume":"33","author":"Gayoso-Diz","year":"2013","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2019.01.009_bib0215","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/ndt\/gfr657","article-title":"Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients","volume":"27","author":"Ibrahim","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2019.01.009_bib0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.ajkd.2012.03.006","article-title":"Study Group Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients","volume":"60","author":"Ibrahim","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2019.01.009_bib0225","unstructured":"DHHS. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (updated on March 13, 2017)."},{"key":"10.1016\/j.nefro.2019.01.009_bib0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14740331003627458","article-title":"Renal toxicity associated with tenofovir use","volume":"9","author":"Rodriguez-N\u00f3voa","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nefro.2019.01.009_bib0235","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAI.0000000000001350","article-title":"A randomized, double-blind comparison of tenofovir alafenamide (TAF) vs. tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E\/C\/F) for initial HIV-1 treatment: week 144 results","volume":"75","author":"Arribas","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.nefro.2019.01.009_bib0240","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/QAD.0b013e32833202e2","article-title":"Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations","volume":"24","author":"Rodr\u00edguez-N\u00f3voa","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.nefro.2019.01.009_bib0245","first-page":"59","article-title":"Renal and bone toxicity with the use of tenofovir: understanding at the end","volume":"18","author":"Casado","year":"2016","journal-title":"AIDS Rev"},{"key":"10.1016\/j.nefro.2019.01.009_bib0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/hiv.12116","article-title":"Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection","volume":"15","author":"Gedela","year":"2014","journal-title":"HIV Med"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519300566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699519300566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:53:58Z","timestamp":1759323238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699519300566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0211699519300566"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2019.01.009","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}